Executive Summary: The contrasting fates of foreign companies in two recent fraud cases suggest that the People’s Republic of China (PRC) treats firms differently depending on their political utility. AstraZeneca has been guilty of widespread medical insurance fraud but has probably been treated leniently by... MORE